Medication info
Telmicure Tablet 80 mg (Telmisartan)

Telmicure Tablet 80 mg (Telmisartan)

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›80mg / 1 tablet
Manufacturer / importer
TerraGen Bio Co., Ltd.
Appearance
White oval tablet
Packaging
30 tablets (10 tablets/Alu-Alu × 3), 30 tablets/bottle
Approval status
Active

MFDS item code 201801336 · Approved 2018.03.27 · Insurance code 698503850

Summary

Main use
Treatment of essential hypertension; reduction of the risk of cardiovascular events (myocardial infarction, stroke, etc.)
Who takes it
Adults
Adult dose
1. Essential hypertension Adults: Administer 40 mg of telmisartan orally once daily with water, with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. This drug produces an additional blood pressure-lowering effect when administered in combination with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: Administration of 80 mg of this drug orally once daily with water is recommended; it may be taken with or without food. The effect on reducing the risk of cardiovascular morbidity and mortality at doses below 80 mg is unknown. When starting treatment with this drug to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive agents may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild to moderate hepatic impairment, and do not exceed 40 mg once daily.

Ingredients

Manufacturer
TerraGen Bio Co., Ltd.

Efficacy & effects

Treatment of essential hypertension; reduction of the risk of cardiovascular events (myocardial infarction, stroke, etc.)

  • Essential hypertension
View approved original text

This medication is used to treat essential hypertension. It also helps reduce the risk of death from myocardial infarction, stroke, and cardiovascular diseases. It is particularly suitable for patients over 55 who are at high risk, such as those with coronary artery disease, peripheral artery disease, stroke, or diabetes, and who cannot use ACE inhibitors. This medication effectively reduces the risk of cardiovascular disease and improves health.

How to take

Adult dose

1. Essential hypertension Adults: Administer 40 mg of telmisartan orally once daily with water, with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. This drug produces an additional blood pressure-lowering effect when administered in combination with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: Administration of 80 mg of this drug orally once daily with water is recommended; it may be taken with or without food. The effect on reducing the risk of cardiovascular morbidity and mortality at doses below 80 mg is unknown. When starting treatment with this drug to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive agents may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild to moderate hepatic impairment, and do not exceed 40 mg once daily.

Precautions

This medication can cause serious harm to the fetus and newborn if used during pregnancy, so it should be discontinued immediately if pregnancy is confirmed. It should not be used by women who are allergic to this drug or its components, those who are pregnant or breastfeeding, patients with severe liver dysfunction, those with a history of certain angioedema, or patients with diabetes or severe renal impairment. Caution is needed for the elderly, patients with hyperkalemia, patients with mild liver dysfunction, and those with heart valve disease or cerebrovascular disease when using this medication. Various adverse reactions, such as infections, hypotension, hyperkalemia, renal impairment, liver dysfunction, and allergic reactions, may occur during the use of this medication, so symptoms should be closely monitored. Particular symptoms such as angioedema, severe hyperkalemia, acute renal failure, shock, interstitial pneumonia, and rhabdomyolysis may occur, and if these abnormal symptoms appear, medication should be stopped immediately and medical consultation is advised. Patients with kidney disease or those undergoing dialysis should regularly undergo blood tests to check kidney function and electrolyte levels, as hypotension symptoms may arise in a state of low blood volume or sodium deficiency. Caution should be taken when using this medication with other antihypertensives as it may enhance the blood pressure-lowering effect, so consultation with healthcare providers is advised. When used in combination with certain drugs, renal function deterioration or electrolyte abnormalities may occur, which requires attention. Women who are pregnant or planning to become pregnant should absolutely avoid using this medication, and breastfeeding women should also avoid taking this medication or discontinue breastfeeding. This medication is not recommended for children under 18 years of age as its safety and efficacy have not been established. Elderly patients should be closely monitored and take it cautiously as excessive hypotension may increase the risk of stroke and other issues. In case of overdose, symptoms such as hypotension, dizziness, and acute renal failure may occur, so immediate treatment at a medical institution is required, as this medication is not removed by dialysis, requiring caution. This medication should be stored out of the reach of children, and it is advisable not to open the package until just before use. Caution should be exercised while driving or operating machinery as fainting or dizziness may occur, and patients with hereditary fructose intolerance should not take this medication.

Side effects

  • Upper respiratory infections
  • pharyngitis
  • sinusitis
  • urinary tract infections
  • cystitis
  • sepsis
  • anemia
  • thrombocytopenia
  • eosinophilia
  • hypersensitivity
Show 108 more
  • anaphylactic reactions
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • depression
  • insomnia
  • anxiety
  • syncope
  • drowsiness
  • visual disturbances
  • dizziness
  • bradycardia
  • tachycardia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • cough
  • interstitial lung disease
  • abdominal pain
  • diarrhea
  • dyspepsia
  • abdominal bloating
  • vomiting
  • abdominal discomfort
  • dry mouth
  • taste disturbances
  • altered liver function
  • liver dysfunction
  • increased sweating
  • itching
  • rash
  • erythema
  • angioedema
  • drug rash
  • toxic skin rash
  • eczema
  • urticaria
  • myalgia
  • low back pain
  • muscle cramps
  • arthralgia
  • limb pain
  • tendon pain
  • acute renal failure
  • chest pain
  • weakness
  • influenza-like illness
  • elevated serum creatinine
  • increased serum uric acid
  • elevated liver enzymes
  • increased serum creatine kinase
  • decreased hemoglobin
  • hypoglycemia
  • fatigue
  • hunger
  • cold sweat
  • tremor
  • decreased concentration
  • convulsions
  • altered consciousness
  • facial swelling
  • lip swelling
  • pharyngeal and laryngeal swelling
  • tongue swelling
  • laryngeal edema
  • severe hyperkalemia
  • renal failure
  • shock
  • loss of consciousness
  • jaundice
  • respiratory distress
  • hypotension
  • laryngeal edema
  • fever
  • pneumonia
  • myalgia
  • elevated creatine kinase
  • increased serum and urinary myoglobin
  • palpitations
  • fatigue
  • nausea
  • inadequate effect
  • headache
  • dizziness
  • facial spasms
  • sensation abnormalities
  • paralysis
  • hyperventilation
  • pneumonia
  • flushing
  • erectile dysfunction
  • loss of appetite
  • arrhythmia
  • weakness
  • edema
  • decreased libido
  • facial edema
  • rash
  • alopecia
  • conjunctivitis
  • tinnitus
  • petechiae
  • arrhythmia
  • intestinal vascular edema
  • abdominal pain
  • nausea
  • vomiting
  • diarrhea

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to avoid the effects of air or moisture. It is best to store it at room temperature between 1°C and 30°C, away from excessively hot or cold places.

Appearance and packaging

Appearance

White oval tablet

Package unit

30 tablets (10 tablets/Alu-Alu × 3), 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.